To date, there has not been a time-efficient and resource-conscious way to identify cognitive
impairment in patients with substance use disorders (SUDs). In this study, we assessed the …

Introduction: Despite the considerable prevalence of cognitive impairment in substance-
using populations, there has been little investigation of the utility of cognitive screening …

Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

Brief neuropsychological tests were administered to an inpatient substance abuse
population to (1) evaluate the status of neurocognitive functioning at admission,(2) assess …

Abstract Introduction and Aims Cognitive impairments in substance use disorder predict
treatment outcome and are assumed to differ between substances. They often go …

Cognitive dysfunction in schizophrenia is well established with neuropsychological
batteries, which have assessed multiple domains indicating diffuse deficits especially in …

The relationship between self-reported cognitive deficits and objectively measured cognitive
performance was examined in 86 patients entering substance abuse treatment. Self-ratings …

Introduction Chronic polysubstance abuse (SUD) is associated with neurophysiological and
neuroanatomical changes. Neurocognitive impairment tends to affect quality of life …

Substance use disorders are frequently undiagnosed in psychiatric settings. One possible
reason for this underdiagnosis is the lack of screening procedures designed or validated …

BACKGROUND: Substance abuse is associated with cognitive impairment. Participation in
clinical addiction research can be cognitively demanding. Screening tools can identify …